NSC19005

CAS No. 5452-87-9

NSC19005( NSC19005 | NSC-19005 | NSC 19005 )

Catalog No. M17535 CAS No. 5452-87-9

NSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 36 In Stock
10MG 59 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC19005
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.
  • Description
    NSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.
  • In Vitro
    Betahistine (0-10 μM) inhibits [125I]iodoproxyfan binding to membranes of CHO (rH3(445)R) and CHO (hH3(445)R) cells with IC50 values of 1.9 μM and 3.3 μM, respectively. Lead to Ki values of 1.4 μM and 2.5 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    NSC19005 | NSC-19005 | NSC 19005
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5452-87-9
  • Formula Weight
    241.34
  • Molecular Formula
    C15H19N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(CCc1ncccc1)CCc1ncccc1
  • Chemical Name
    N-methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethan-1-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lewin JL,et al.Validation of density functional modeling protocols on experimental bis(mu-oxo)/mu-eta2:eta2-peroxo dicopper equilibria. J Biol Inorg Chem. 2007 Nov;12(8):1221-34.
molnova catalog
related products
  • Arachidic acid

    Arachidic acid is a saturated fatty acid found naturally in fish and vegetable oils. It can also be formed by the hydrogenation of arachidonic acid.

  • JI130

    JI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.

  • Axitinib-13C-d3

    Axitinib-13C,d3 is a 13C-labeled and deuterium labeled Axitinib. Axitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3 andPDGFRβ, respectively.